EGFR and cancer: Although the concurrent treatment with autophagy inhibitors and EGFR inhibitors has been attracting much attention as a novel anti-cancer strategy, it is still an open question whether autophagy inhibits cancer cell proliferation or promotes cancer cell survival under harsh circumstances, such as under TKI treatments.